Proprietary Biomedical Technology Platform for Longevity and Preventive Health

This biomedical technology business offers a proprietary software platform designed to help clients worldwide take a data-driven approach to longevity and preventive health. The platform integrates data across multiple biological domains—genetics, epigenetics, immunology, metabolism, neurology, biomedical imaging, and blood lab results—to provide each client with a comprehensive picture of their biological health. The business model is built on a recurring revenue structure, with each client paying an annual fee of $45,000. The company was established in 2025 and has achieved zero customer acquisition cost, indicating strong organic growth or inherent market demand. This represents a scalable technology-driven business with significant potential in the growing preventive health and longevity market.